These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 31923305

  • 21. Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.
    Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfield R, Aragon D, Zansky SM, Watt JP, Cieslak PR, Angeles K, Harrison LH, Petit S, Beall B, Van Beneden CA.
    Clin Infect Dis; 2016 Aug 15; 63(4):478-86. PubMed ID: 27105747
    [Abstract] [Full Text] [Related]

  • 22. Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
    Sierra JM, Sánchez F, Castro P, Salvadó M, de la Red G, Libois A, Almela M, March F, Español M, Sambeat MA, Romeu J, Brugal MT, de Olalla PG, Gatell JM, Vila J, García F, Colomés JLL, Caylà JA, Coll P.
    Medicine (Baltimore); 2006 May 15; 85(3):139-146. PubMed ID: 16721256
    [Abstract] [Full Text] [Related]

  • 23. [Beta-hemolytic streptococcal bacteremia in adults].
    Rantala S.
    Duodecim; 2013 May 15; 129(14):1477-84. PubMed ID: 23961606
    [Abstract] [Full Text] [Related]

  • 24. Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus.
    Aronoff DM, Bloch KC.
    Medicine (Baltimore); 2003 Jul 15; 82(4):225-35. PubMed ID: 12861100
    [Abstract] [Full Text] [Related]

  • 25. Effect of underlying immune compromise on the manifestations and outcomes of group A streptococcal bacteremia.
    Linder KA, Alkhouli L, Ramesh M, Alangaden GA, Kauffman CA, Miceli MH.
    J Infect; 2017 May 15; 74(5):450-455. PubMed ID: 28237623
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.
    Ekelund K, Skinhøj P, Madsen J, Konradsen HB.
    J Clin Microbiol; 2005 Apr 15; 43(4):1789-96. PubMed ID: 15815000
    [Abstract] [Full Text] [Related]

  • 29. Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.
    Horn DL, Roberts EA, Shen J, Chan JD, Bulger EM, Weiss NS, Lynch JB, Bryson-Cahn C, Robinson BRH.
    Clin Infect Dis; 2021 Dec 06; 73(11):e4592-e4598. PubMed ID: 33151283
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model.
    Tarnutzer A, Andreoni F, Keller N, Zürcher C, Norrby-Teglund A, Schüpbach RA, Zinkernagel AS.
    Clin Microbiol Infect; 2019 Apr 06; 25(4):512.e7-512.e13. PubMed ID: 30025835
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular characterization and antimicrobial resistance of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2013 to 2018.
    Ikebe T, Okuno R, Kanda Y, Sasaki M, Yamaguchi T, Otsuka H, Kazawa Y, Suzuki M, Ohya H, Uchida K, Ohnishi M, Working Group for Beta-Hemolytic Streptococci in Japan.
    Int J Med Microbiol; 2021 Apr 06; 311(3):151496. PubMed ID: 33756191
    [Abstract] [Full Text] [Related]

  • 34. [Epidemiology of Streptococcus pyogenes invasive diseases in France (2007-2011)].
    Plainvert C, Loubinoux J, Bidet P, Doloy A, Touak G, Dmytruk N, Collobert G, Bingen E, Bouvet A, Fouet A, Poyart C.
    Arch Pediatr; 2014 Nov 06; 21 Suppl 2():S62-8. PubMed ID: 25456682
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.
    Ikebe T, Okuno R, Sasaki M, Kanda Y, Otsuka H, Kawahara R, Ohya H, Suzuki M, Uchida K, Nihonmatsu H, Ohnishi M, Working Group for Beta-Hemolytic Streptococci in Japan.
    J Infect Chemother; 2018 Feb 06; 24(2):117-122. PubMed ID: 29107650
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A case of streptococcal toxic shock syndrome due to Group G streptococci identified as Streptococcus dysgalactiae subsp. equisimilis.
    Nei T, Akutsu K, Shima A, Tsuboi I, Suzuki H, Yamamoto T, Tanaka K, Shinoyama A, Kojima Y, Washio Y, Okawa S, Sonobe K, Norose Y, Saito R.
    J Infect Chemother; 2012 Dec 06; 18(6):919-24. PubMed ID: 22327489
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.